Recent Advances in the Treatment of Interstitial Lung Disease in Patients with Polymyositis/Dermatomyositis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 409-415

Bentham Science Publishers

Access to resources Recommend Favorite

Ciclosporin: Lack of efficacy in interstitial pneumonia associated with amyopathic dermatomyositis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Cyclophosphamide for scleroderma interstitial lung disease

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 393-395

Informa Healthcare

Access to resources Recommend Favorite

Red blood cell distribution width and neutrophil to lymphocyte ratio are correlated with disease activity of dermatomyositis and polymyositis

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of imatinib appears to be associated with interstitial lung disease (ILD) in patients with chronic myeloid leukaemia (CML)

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite